Last quarter (Q4 2023), Kronos Bio's total revenue was $2.30M, an increase of Infinity% from the same quarter last year. In Q4, Kronos Bio's net income was $-25.32M. See Kronos Bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 6.32M	$ 6.30M	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 6.30M	$ 6.30M	-	-	-	-
Operating Expense	$ 128.12M	$ 128.12M	$ 137.12M	$ 151.40M	$ 58.04M	$ 16.82M
Operating Income	$ -121.85M	$ -121.83M	$ -137.12M	$ -151.40M	$ -58.04M	$ -16.82M
Net Non Operating Interest Income Expense	-	-	-	-	$ -2.99M	$ 699.00K
Other Income Expense	$ -9.16M	$ -9.16M	$ -3.91M	$ -320.00K	$ -27.41M	-
Pretax Income	$ -112.66M	$ -112.66M	$ -133.20M	$ -151.08M	$ -88.44M	$ -16.12M
Tax Provision	$ -4.42M	$ -4.42M	$ -5.02M	$ -615.00K	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -112.69M	$ -112.67M	$ -133.20M	$ -151.08M	$ -88.44M	$ -16.12M
Basic EPS	$ -1.95	$ -1.95	$ -2.37	$ -2.76	$ -5.43	$ -0.77
Diluted EPS	$ -1.95	$ -1.95	$ -2.37	$ -2.76	$ -5.43	$ -0.77
Basic Average Shares	$ 230.98M	$ 57.74M	$ 56.20M	$ 54.75M	$ 16.28M	$ 20.90M
Diluted Average Shares	$ 230.98M	$ 57.74M	$ 56.20M	$ 54.75M	$ 16.28M	$ 20.90M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 128.12M	$ 128.12M	$ 137.12M	$ 151.40M	$ 58.04M	$ 16.82M
Net Income From Continuing And Discontinued Operation	$ -112.67M	$ -112.67M	$ -133.20M	$ -151.08M	$ -88.44M	$ -16.12M
Normalized Income	$ -29.72M	$ -114.17M	-	-	$ -88.44M	$ -16.12M
Interest Expense	-	-	-	-	$ 3.89M	$ 3.00K
EBIT	$ -108.25M	$ -112.66M	$ -133.20M	$ -151.08M	$ -84.55M	$ -16.11M
EBITDA	$ -104.25M	$ -113.12M	$ -129.24M	$ -142.98M	$ -83.72M	$ -15.76M

Currency in USD

Kronos Bio Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing